LLMpediaThe first transparent, open encyclopedia generated by LLMs

Jackson Heart Study

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Framingham Heart Study Hop 3
Expansion Funnel Raw 39 → Dedup 6 → NER 3 → Enqueued 3
1. Extracted39
2. After dedup6 (None)
3. After NER3 (None)
Rejected: 3 (not NE: 3)
4. Enqueued3 (None)
Jackson Heart Study
NameJackson Heart Study
CaptionCohort participants in Jackson, Mississippi
LocationJackson, Mississippi
Founded1998
InvestigatorsNational Heart, Lung, and Blood Institute, University of Mississippi Medical Center, Jackson State University, Tougaloo College
Participants~5,300 African American adults
FocusCardiovascular disease, hypertension, stroke, heart failure

Jackson Heart Study

The Jackson Heart Study is a large, community-based cohort study focused on cardiovascular disease in African American adults in Jackson, Mississippi and surrounding counties. It was established to investigate risk factors for coronary heart disease, stroke, and related conditions by combining clinical examinations, laboratory assays, imaging, and social-behavioral assessments. The study has produced influential findings informing public health policy, clinical practice, and subsequent cohort efforts.

Overview

The cohort enrolled approximately 5,300 African American adults and integrates longitudinal clinical visits, biorepository samples, and linkage to administrative data to study incident myocardial infarction, heart failure, stroke, and mortality. Core institutions include University of Mississippi Medical Center, Jackson State University, and Tougaloo College, with primary funding and scientific oversight from the National Heart, Lung, and Blood Institute and collaborations with clinical laboratories, imaging centers, and epidemiologic consortia. The study employs standardized protocols for blood pressure, electrocardiography, echocardiography, and biomarker assays to permit comparisons with cohorts such as the Framingham Heart Study, Atherosclerosis Risk in Communities Study, and CARDIA.

History and funding

Conceptual planning began in the 1990s as part of initiatives to reduce racial disparities following national reports on minority health. Initial funding was awarded by the National Heart, Lung, and Blood Institute in the late 1990s, with operational leadership distributed among University of Mississippi Medical Center, Jackson State University, and Tougaloo College. Additional support and collaborative grants have involved the National Institutes of Health, private foundations, and cooperative agreements with regional hospitals and public health agencies. The design and launch reflected input from community advisory boards and stakeholders who had ties to civic institutions in Hinds County, Mississippi, Rankin County, Mississippi, and Madison County, Mississippi.

Study design and methods

The longitudinal design includes baseline examination, repeat visits, annual surveillance, and adjudication of cardiovascular events by physician committees. Data collection comprises physical measures (blood pressure, anthropometry), laboratory analyses (lipids, glucose, biomarkers), imaging (echocardiography, electrocardiography), and questionnaires on medication use, diet, physical activity, and psychosocial factors. Genomic and omics assays were later incorporated, enabling genome-wide association studies and integration with consortia such as the Cohorts for Heart and Aging Research in Genomic Epidemiology and collaborations with the University of Pennsylvania, Harvard T.H. Chan School of Public Health, and other academic centers. Event validation leverages linkage to hospital records, death certificates, and adjudication protocols similar to those used in the Multi-Ethnic Study of Atherosclerosis.

Key findings and publications

Key publications have characterized high prevalence of hypertension, earlier onset of systolic dysfunction, and unique biomarker profiles among African American participants relative to other cohorts like Framingham Heart Study and CARDIA. Studies documented associations between socioeconomic indicators, neighborhood factors, and cardiovascular risk, and identified genetic variants and pathways implicated in blood pressure regulation and heart failure risk. Major papers appeared in journals including The New England Journal of Medicine, Journal of the American Medical Association, Circulation, and Hypertension and often involved collaborators from Johns Hopkins University, Cleveland Clinic, Mayo Clinic, Columbia University, University of California, San Francisco, and Brigham and Women's Hospital.

Impact on cardiovascular health disparities

Findings have informed clinical guideline discussions and public health interventions addressing hypertension control, stroke prevention, and heart failure management in African American communities. The study’s evidence contributed to initiatives by state health departments, local clinics, and national advisory panels including committees affiliated with the Centers for Disease Control and Prevention and the American Heart Association. By elucidating social determinants, access-to-care correlates, and genetic contributors, the cohort influenced risk prediction models and targeted prevention programs in regions affected by elevated cardiovascular mortality such as parts of the Stroke Belt.

Participants and community engagement

Recruitment and retention strategies emphasized partnerships with faith-based organizations, civic leaders, and regional health care providers to build trust and ensure culturally appropriate protocols. Community advisory boards and outreach teams worked with churches, community centers, and local media outlets to support enrollment and follow-up. The study provided feedback on clinical results to participants and coordinated referrals with health systems including Mississippi State Department of Health and regional hospitals to address uncontrolled hypertension and diabetes.

Data access and legacy studies

De-identified datasets, biospecimens, and ancillary study data have been shared through data use agreements with investigators at institutions such as Duke University, University of North Carolina at Chapel Hill, University of Michigan, and international collaborators. Ancillary and legacy studies leveraged the cohort for genomic analyses, intervention trials, and comparative effectiveness research linked to consortia like NHLBI initiatives and other large cohorts including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities Study. The repository and methods legacy continue to support research on cardiovascular disparities, translational biomarkers, and population health interventions.

Category:Epidemiological studies